GB9812189D0 - Methods and compositions for increasing penetration of HIV protease inhibitors - Google Patents

Methods and compositions for increasing penetration of HIV protease inhibitors

Info

Publication number
GB9812189D0
GB9812189D0 GBGB9812189.0A GB9812189A GB9812189D0 GB 9812189 D0 GB9812189 D0 GB 9812189D0 GB 9812189 A GB9812189 A GB 9812189A GB 9812189 D0 GB9812189 D0 GB 9812189D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
protease inhibitors
hiv protease
increasing penetration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9812189.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9812189.0A priority Critical patent/GB9812189D0/en
Publication of GB9812189D0 publication Critical patent/GB9812189D0/en
Priority to PCT/EP1999/003827 priority patent/WO1999064001A2/en
Priority to EP99927848A priority patent/EP1094814A2/en
Priority to AU45051/99A priority patent/AU4505199A/en
Priority to JP2000553070A priority patent/JP2002517443A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB9812189.0A 1998-06-05 1998-06-05 Methods and compositions for increasing penetration of HIV protease inhibitors Ceased GB9812189D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9812189.0A GB9812189D0 (en) 1998-06-05 1998-06-05 Methods and compositions for increasing penetration of HIV protease inhibitors
PCT/EP1999/003827 WO1999064001A2 (en) 1998-06-05 1999-06-03 Methods and compositions for increasing penetration of hiv protease inhibitors
EP99927848A EP1094814A2 (en) 1998-06-05 1999-06-03 Methods and compositions for increasing penetration of hiv protease inhibitors
AU45051/99A AU4505199A (en) 1998-06-05 1999-06-03 Methods and compositions for increasing penetration of hiv protease inhibitors
JP2000553070A JP2002517443A (en) 1998-06-05 1999-06-03 Methods and compositions for increasing penetration of HIV protease inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812189.0A GB9812189D0 (en) 1998-06-05 1998-06-05 Methods and compositions for increasing penetration of HIV protease inhibitors

Publications (1)

Publication Number Publication Date
GB9812189D0 true GB9812189D0 (en) 1998-08-05

Family

ID=10833305

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9812189.0A Ceased GB9812189D0 (en) 1998-06-05 1998-06-05 Methods and compositions for increasing penetration of HIV protease inhibitors

Country Status (5)

Country Link
EP (1) EP1094814A2 (en)
JP (1) JP2002517443A (en)
AU (1) AU4505199A (en)
GB (1) GB9812189D0 (en)
WO (1) WO1999064001A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
JP2000072749A (en) * 1998-08-24 2000-03-07 Mitsui Chemicals Inc Apoptosis-inducing agent using quinoline derivative
JP2000290181A (en) * 1999-04-01 2000-10-17 Mitsui Chemicals Inc Intracerebral migration potentiator for encephalopathy therapeutic agent
WO2002098849A2 (en) 2001-06-01 2002-12-12 Elan Pharmaceuticals, Inc. Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
CA2450205A1 (en) 2001-06-13 2002-12-19 Elan Pharmaceuticals, Inc. Aminediols for the treatment of alzheimer's disease
WO2003006013A1 (en) 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Diaminediols for the treatment of alzheimer's disease
MXPA04000337A (en) 2001-07-10 2004-07-23 Upjohn Co Aminediols for the treatment of alzheimer's disease.
WO2003029169A2 (en) 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
BR0214736A (en) 2001-12-06 2004-11-23 Elan Pharm Inc Compound and its pharmaceutically acceptable salts, pharmaceutical composition and method of treating humans or animals suffering from diseases or conditions
WO2004058686A1 (en) 2002-04-30 2004-07-15 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of alzheimer’s disease
CL2004000849A1 (en) 2003-04-21 2005-01-28 Elan Pharmaceuticals Inc Pharm COMPOUNDS DERIVED FROM BENZAMIDAS-2-HIDROXI-3-DIAMINOALCANS, USEFUL FOR THE TREATMENT OR PREVENTION OF ALZHEIMER, DOWN SYNDROME, HEREDITARY CEREBRAL HEMORRAGY, DEGENERATIVE DEMENCIES AND OTHERS.
JP2007528400A (en) 2004-03-09 2007-10-11 エラン ファーマシューティカルズ，インコーポレイテッド Substituted hydroxyethylamine aspartic protease inhibitors
JP2007533740A (en) 2004-04-22 2007-11-22 イーライ リリー アンド カンパニー Amides as BACE inhibitors
US7385085B2 (en) 2004-07-09 2008-06-10 Elan Pharmaceuticals, Inc. Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
US20140275139A1 (en) * 2013-03-12 2014-09-18 Hiv Diagnostics, Inc. Mdr method and products for treating hiv/aids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT68856A (en) * 1991-01-11 1995-08-28 Glaxo Lab Sa Acridine derivatives, pharmaceutical compositions comprising the same compouds as effective substances and a process for producing the compounds and the pharmaceutical compositions
MY126358A (en) * 1996-03-22 2006-09-29 Glaxo Group Ltd Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents

Also Published As

Publication number Publication date
WO1999064001A3 (en) 2000-02-03
AU4505199A (en) 1999-12-30
WO1999064001A2 (en) 1999-12-16
EP1094814A2 (en) 2001-05-02
JP2002517443A (en) 2002-06-18

Similar Documents

Publication Publication Date Title
GB9812189D0 (en) Methods and compositions for increasing penetration of HIV protease inhibitors
HUP0105077A3 (en) Serine protease inhibitors and pharmaceutical compositions containing them
IL128664A (en) Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them
HK1039110A1 (en) Novel compounds and compositions as protease inhibitors
HUP0103806A3 (en) Serine protease inhibitor and pharmaceutical compositions containing them
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
IL120311A0 (en) Serine protease inhibitors and pharmaceutical compositions containing them
IL120310A0 (en) Serine protease inhibitors and pharmaceutical compositions containing them
AU5956001A (en) Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
HUP0101640A3 (en) Certain thoil inhibitors of endothelin-converting enzyme
GB2348199B (en) Corrosion inhibitor compositions and methods of making them
IL135122A0 (en) Isoquinolines as urokinase inhibitors
EP1162934A4 (en) Compositions and methods for prevention of photoaging
AU2001224021A1 (en) Compositions for protecting plants and method of using the same
SG94728A1 (en) Method of cutting csp substrates
EP1075184A4 (en) Compositions and methods for active vaccination
PL342602A1 (en) Method of synthesising inhibitors of hiv protease
AU2002303552A8 (en) Methods and compositions for prevention of angioproliferation
AU4980400A (en) Compositions and methods for detection of active proteases
AU5089699A (en) Methods of making dihydropyrone hiv protease inhibitors
GB0026944D0 (en) Improved cutting tool and method of making same
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
PL346022A1 (en) Isoquinolines as urokinase inhibitors
EP0912170A4 (en) Hiv protease inhibitors useful for the treatment of aids
AU5913199A (en) Methazolamide compositions and method of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)